Wolfgang Fischer

Chief Operating Officer at AFFIMED N.V.

Net worth: 710 221 $ as of 2024-04-29

60 year

Consumer Services

Commercial Services

Health Technology

Wolfgang Fischer active positions

Companies	Position	Start	End
AFFIMED N.V.	Chief Operating Officer	2017-09-12	-
Affimed GmbH Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.	Chief Operating Officer	2016-12-31	-

Companies	Position	Start	End
Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.	Corporate Officer/Principal	2002-12-31	-

Swiss Federal Institute of Technology	Doctorate Degree
University of Würzburg Medical School	Doctorate Degree

International

Germany	5
Switzerland	2

Operational

Chief Operating Officer	2
Doctorate Degree	2
Corporate Officer/Principal	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
AFFIMED N.V.	Health Technology

Private companies	2
Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.	Commercial Services
Affimed GmbH Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010.	Commercial Services

Private companies

Commercial Services